// App-Quantinova.ai

4049 : Pembrolizumab for patients with previously treated metastatic adenocarcinoma or squamous cell carcinoma of the esophagus: Phase 2 KEYNOTE-180 study.

Researchers

Presenter

  • Manish A. Shah

Principal Investigators

  • Peter C. Enzinger

  • Daniel Hochhauser

  • Judith Raimbourg

  • Antoine Hollebecque

  • Florian Lordick

  • Sung-Bae Kim

  • Masahiro Tajika

  • Heung Tae Kim

  • Albert Craig Lockhart

  • Hendrik-Tobias Arkenau

  • Farid El Hajbi

  • Mukul Gupta

  • Per Pfeiffer

  • Qi Liu

  • Jared Lunceford

  • S. Peter Kang

  • Pooja Bhagia

  • Ken Kato

Medical Centers

  • Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY

  • Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan, Kashiwa, Japan

  • Dana-Farber Cancer Institute, Boston, MA

  • University College London Hospitals/UCL Cancer Institute, London, United Kingdom

  • Institut de Cancerologie de l'Ouest Paul Papin, Angers, France

  • Gustave Roussy, Villejuif, France

  • University Cancer Center Leipzig, Leipzig, Germany

  • Aichi Cancer Center Hospital, Nagoya, Japan

  • University of Miami/Sylvester Cancer Center, Miami, FL

  • Sarah Cannon Research Institute, London, United Kingdom

  • Centre Oscar Lambret, Lille, France

  • Sansum Clinic, Santa Barbara, CA

  • Department of Oncology, Odense University Hospital, Odense, Denmark

  • Merck & Co., Inc., Kenilworth, NJ

  • Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

Locations

  • Japan

  • Germany

  • United Kingdom

  • United States

  • France

  • Denmark

Companies

  • Merck & Co., Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • NCT02559687

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved